Literature DB >> 26850169

Structural characterization of GASDALIE Fc bound to the activating Fc receptor FcγRIIIa.

Alysia A Ahmed1, Sravya R Keremane1, Jost Vielmetter1, Pamela J Bjorkman2.   

Abstract

The Fc region of Immunoglobulin G (IgG) initiates inflammatory responses such as antibody-dependent cell-mediated cytotoxicity (ADCC) through binding to activating Fc receptors (FcγRI, FcγRIIa, FcγRIIIa). These receptors are expressed on the surface of immune cells including macrophages, dendritic cells, and natural killer cells. An inhibitory receptor, FcγRIIb, is expressed on macrophages and other myeloid leukocytes simultaneously with the activating receptor FcγRIIa, thereby setting a threshold for cell activation. The affinity of IgG Fc for binding activating Fc receptors depends on IgG subclass and the composition of N-linked glycans attached to a conserved asparagine in the Fc CH2 domain. For example, Fc regions with afucosylated glycans bind more tightly to FcγRIIIa than fucosylated Fc, and afucosylated Fcs exhibit enhanced ADCC activity in vivo and in vitro. Enhanced pro-inflammatory responses have also been seen for Fc regions with amino acid substitutions. GASDALIE Fc is an Fc mutant (G236A/S239D/A330L/I332E) that exhibits a higher affinity for FcγRIIIa and increased effector functions in vivo compared to wild-type Fc. To explore its altered functions, we compared the affinities of GASDALIE and wild-type Fc for activating and inhibitory FcγRs. We also determined the crystal structure of GASDALIE Fc alone and bound to FcγRIIIa. The overall structure of GASDALIE Fc alone was similar to wild-type Fc structures, however, increased electrostatic interactions in the GASDALIE Fc:FcγRIIIa interface compared with other Fc:FcγR structures suggest a mechanism for the increased affinity of GASDALIE Fc for FcγRIIIa.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Affinity; Fc receptors; Fc–FcR structure; GASDALIE Fc; IgG Fc; SDALIE Fc

Mesh:

Substances:

Year:  2016        PMID: 26850169      PMCID: PMC4769027          DOI: 10.1016/j.jsb.2016.02.001

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  55 in total

1.  Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.

Authors:  P Sondermann; J Kaiser; U Jacob
Journal:  J Mol Biol       Date:  2001-06-08       Impact factor: 5.469

2.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

3.  Identification of a receptor required for the anti-inflammatory activity of IVIG.

Authors:  Robert M Anthony; Fredrik Wermeling; Mikael C I Karlsson; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-26       Impact factor: 11.205

Review 4.  IgG Fc receptors.

Authors:  J V Ravetch; S Bolland
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor.

Authors:  A Samuelsson; T L Towers; J V Ravetch
Journal:  Science       Date:  2001-01-19       Impact factor: 47.728

Review 6.  The impact of glycosylation on the biological function and structure of human immunoglobulins.

Authors:  James N Arnold; Mark R Wormald; Robert B Sim; Pauline M Rudd; Raymond A Dwek
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  pH dependence and stoichiometry of binding to the Fc region of IgG by the herpes simplex virus Fc receptor gE-gI.

Authors:  Elizabeth R Sprague; W Lance Martin; Pamela J Bjorkman
Journal:  J Biol Chem       Date:  2004-01-20       Impact factor: 5.157

9.  Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1.

Authors:  Shigeki Matsumiya; Yoshiki Yamaguchi; Jun-ichi Saito; Mayumi Nagano; Hiroaki Sasakawa; Shizuo Otaki; Mitsuo Satoh; Kenya Shitara; Koichi Kato
Journal:  J Mol Biol       Date:  2007-02-22       Impact factor: 5.469

10.  General mechanism for modulating immunoglobulin effector function.

Authors:  Peter Sondermann; Andrew Pincetic; Jad Maamary; Katja Lammens; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-22       Impact factor: 11.205

View more
  16 in total

1.  Characterization of Mauritian Cynomolgus Macaque FcγR Alleles Using Long-Read Sequencing.

Authors:  Amelia K Haj; Jaren M Arbanas; Aaron P Yamniuk; Julie A Karl; Hailey E Bussan; Kenneth Y Drinkwater; Michael E Graham; Adam J Ericsen; Trent M Prall; Kristina Moore; Lin Cheng; Mian Gao; Robert F Graziano; John T Loffredo; Roger W Wiseman; David H O'Connor
Journal:  J Immunol       Date:  2018-12-10       Impact factor: 5.422

2.  Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir.

Authors:  Shariq Mujib; Jun Liu; A K M Nur-Ur Rahman; Jordan A Schwartz; Phil Bonner; Feng Yun Yue; Mario A Ostrowski
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

Review 3.  Vaccinal antibodies: Fc antibody engineering to improve the antiviral antibody response and induce vaccine-like effects.

Authors:  Dhuha H Nawab
Journal:  Hum Vaccin Immunother       Date:  2021-11-29       Impact factor: 3.452

Review 4.  From CD16a Biology to Antibody-Dependent Cell-Mediated Cytotoxicity Improvement.

Authors:  Loïs Coënon; Martin Villalba
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

Review 5.  Antibodies for Human Immunodeficiency Virus-1 Cure Strategies.

Authors:  Evan Rossignol; Galit Alter; Boris Julg
Journal:  J Infect Dis       Date:  2021-02-15       Impact factor: 5.226

Review 6.  Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV.

Authors:  Deborah J Anderson; Joseph A Politch; Larry Zeitlin; Andy Hiatt; Kadryn Kadasia; Kenneth H Mayer; Ruth M Ruprecht; Francois Villinger; Kevin J Whaley
Journal:  AIDS       Date:  2017-07-17       Impact factor: 4.632

7.  Mouse IgG2c Fc loop residues promote greater receptor-binding affinity than mouse IgG2b or human IgG1.

Authors:  Daniel J Falconer; Adam W Barb
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

Review 8.  Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life.

Authors:  Kevin O Saunders
Journal:  Front Immunol       Date:  2019-06-07       Impact factor: 7.561

9.  Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity.

Authors:  Kristina Ellwanger; Uwe Reusch; Ivica Fucek; Susanne Wingert; Thorsten Ross; Thomas Müller; Ute Schniegler-Mattox; Torsten Haneke; Erich Rajkovic; Joachim Koch; Martin Treder; Michael Tesar
Journal:  MAbs       Date:  2019-06-07       Impact factor: 5.857

Review 10.  Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections.

Authors:  Shamus P Keeler; Julie M Fox
Journal:  Viruses       Date:  2021-05-31       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.